Cogentix Medical (NASDAQ: CGNT) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $116 million versus the consensus estimate of $115.57 million.

GUIDANCE:

Cogentix Medical sees FY2021 EPS of $0.82, versus the consensus of $0.80. Cogentix Medical sees FY2021 revenue of $490 million, versus the consensus of $489 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.